Sponsored by:

Survival Guide: Emergency Preparedness without Breaking a Bank
9:45am – 11:00am

The majority of U.S. companies have a formal, written plan for emergency preparedness. However, there is a sea of difference between a plan that gathers dust on the shelf and a viable plan that can be deployed. An effective plan is dynamic, not static. It requires regular risk audits, with the mitigation and activation of backup facilities being key elements. Stretching every dollar is critical for small and medium sized life sciences companies. This session will focus on strategic assessment processes, including a discussion of how to cap costs and how to survive without losing development momentum. The current financial crisis resulted in additional pressure placed on smaller life sciences companies: while many of them cannot afford to miss a single deadline without being punished by investors and shareholders, they also have to be conscious of skyrocketing operating costs. A case study of the emergency preparedness plan at Theravance, Inc. will provide attendees with insight in how to make the most of your resources and to get your company through a possible interruption of business operations, while saving some money along the way.

Panel Speakers:
Skip Williams
Preseident, KingsBridge Disaster Recovery

Lenka Barrettova
EH&S Coordinator, Theravance, Inc.

A Shrinking Budget: Opportunities and Pitfalls
11:30am – 12:45pm

In the current financial environment, mid- and large-cap companies are cutting their operating budgets. Many small and therefore chronically underfunded companies do not have a large operating budget to begin with. Increasingly managers are asked to run facilities on a shoe string budget or outsource facilities and operations altogether. A panel of industry professionals will discuss what day-to-day operational savings can be reasonably achieved, which trade-offs should be expected and where to draw a line between savings and quality.

Panel Moderator:
Dawn Hocevar
Director of Business Development, BioSurplus, Inc.

Panel Speakers:
Dee Conger
Chief Executive Officer, Innovive Inc.

Jennifer Pratt Mead
Director, Operations & Administration, Five Prime Therapeutics, Inc.

Derek Apodaca
Director, Facilities - Purchasing, Metabolex, Inc.

Planning for Growth
3:00pm – 4:15pm

Northern California is known and respected for its tradition of innovation in the life sciences sector. Many world leading life sciences companies call California home, while others maintain strong representation in the region. However, once the basic research is done and clinical trials are behind them – companies are looking elsewhere for manufacturing. A case study of a recently announced $100 Million investment by Bayer HealthCare in the Berkeley Manufacturing Center demonstrates that opportunities at home exist and support from both the State and the local communities for Northern California life sciences companies is available. As part of this session, a team that put together the Bayer Berkeley Manufacturing incentive package will discuss how they worked toward a common goal, what they had to do in order to pull this deal off in just three months, and what incentives exist for other companies.

Panel Speakers:
To be announced shortly